Kimberly-Clark Corp (KMB)

KMB (NYSE:Consumer Non-Durables) EQUITY
$110.72
neg -1.10
-0.99%
Today's Range: 111.22 - 111.74 | KMB Avg Daily Volume: 1,546,100
Last Update: 05/26/15 - 9:44 AM EDT
Volume: 1,022,741
YTD Performance: -3.71%
Open: $111.65
Previous Close: $111.83
52 Week Range: $99.20 - $119.01
Oustanding Shares: 364,099,179
Market Cap: 40,506,033,664
6-Month Chart
TheStreet Ratings Grade for KMB
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 2 1 2 1
Moderate Buy 1 1 1 1
Hold 9 10 8 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.58 2.75 2.55 2.73
Latest Dividend: 0.88
Latest Dividend Yield: 3.16%
Dividend Ex-Date: 06/03/15
Price Earnings Ratio: 28.38
Price Earnings Comparisons:
KMB Sector Avg. S&P 500
28.38 28.50 27.04
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
0.26% 1.02% 41.40%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.80 -0.05 -0.02
Net Income -28.20 -0.08 -0.03
EPS -27.00 0.01 0.00
Earnings for KMB:
EBITDA 3.84B
Revenue 19.72B
Average Earnings Estimates
Qtr (06/15) Qtr (09/15) FY (12/15) FY (12/16)
Average Estimate $1.36 $1.52 $5.75 $6.21
Number of Analysts 8 7 10 10
High Estimate $1.39 $1.58 $5.80 $6.31
Low Estimate $1.33 $1.48 $5.68 $6.05
Prior Year $1.49 $1.61 $5.51 $5.75
Growth Rate (Year over Year) -8.81% -5.32% 4.37% 7.89%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
Higher timeframe swing traders can look to enter HON around $100.
Bullish
May 13, 2015 | 7:56 AM EDT
KMB was upgraded from Equal-weight to Overweight, Barclays said. $124 price target. Organic sales growth should outperform the industry...
Here's what stocks would do well with a strong dollar.
Update
Apr 30, 2015 | 6:34 AM EDT
KMB - Kimberly-Clark Corp Annual Shareholders Meeting - 11AM
March quarter earnings take a front seat.
Biotech companies are saying, "I do."
U.S. stocks follow Europe's lead.
The jobs report actually indicates the dollar has peaked. 
That portfolio managers haven't figured this out yet is a negative.
Wall Street earnings forecasts aren't too optimistic.

Columnist Conversations

The Germany iShares (EWG) fund has been unable to make a new closing high this month, and diverged from the S&...
A new recession could be in the cards for the U.S., warns an European strategist who is known for his bearish ...
You really get the sense from recent comments from Fed officials, such as Yellen and Fischer, that a good data...

REAL MONEY'S BEST IDEAS

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.